NYSEAMERICAN:RVP - Retractable Technologies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.8298 -0.01 (-1.19 %)
(As of 07/22/2018 04:00 PM ET)
Previous Close$0.8298
Today's Range$0.82 - $0.8701
52-Week Range$0.54 - $1.48
Volume67,255 shs
Average Volume240,955 shs
Market Capitalization$31.74 million
P/E RatioN/A
Dividend YieldN/A
Beta0.15
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety medical products for the healthcare industry in the United States and internationally. It principally offers VanishPoint safety products comprising tuberculin, insulin, and allergy antigen syringes; autodisable syringes; IV catheters; blood collection tube holders; and blood collection sets, as well as Patient Safe products, including syringes and Luer caps. The company also develops EasyPoint needles. In addition, it is developing retractable needles and syringes, glass syringes, dental syringes, and IV catheter introducers. Retractable Technologies, Inc. serves healthcare providers, such as acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, long-term care facilities, veterans administration facilities, military organizations, public health facilities, and prisons. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was founded in 1994 and is headquartered in Little Elm, Texas.

Receive RVP News and Ratings via Email

Sign-up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:RVP
CUSIPN/A
Phone+1-972-2941010

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-0.64%
Return on Equity-3.58%
Return on Assets-0.67%

Miscellaneous

EmployeesN/A
Outstanding Shares32,670,000
Market Cap$31.74

Retractable Technologies (NYSEAMERICAN:RVP) Frequently Asked Questions

What is Retractable Technologies' stock symbol?

Retractable Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "RVP."

How were Retractable Technologies' earnings last quarter?

Retractable Technologies, Inc. (NYSEAMERICAN:RVP) announced its quarterly earnings data on Tuesday, May, 15th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $7.67 million for the quarter. Retractable Technologies had a negative return on equity of 3.58% and a negative net margin of 0.64%. View Retractable Technologies' Earnings History.

When is Retractable Technologies' next earnings date?

Retractable Technologies is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for Retractable Technologies.

What is the consensus analysts' recommendation for Retractable Technologies?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Retractable Technologies in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are some of Retractable Technologies' key competitors?

Who are Retractable Technologies' key executives?

Retractable Technologies' management team includes the folowing people:
  • Mr. Thomas J. Shaw, Founder, Chairman, Pres & CEO (Age 67)
  • Mr. Douglas W. Cowan, VP, CFO, Treasurer, Principal Accounting Officer & Director (Age 75)
  • Ms. Kathryn M. Duesman, Exec. Director of Global Health (Age 55)
  • Mr. Russell B. Kuhlman, VP of Sales Devel. (Age 64)
  • Hafiz Darren E. Findley, Independent Director (Age 54)

Has Retractable Technologies been receiving favorable news coverage?

Headlines about RVP stock have been trending somewhat positive recently, Accern reports. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Retractable Technologies earned a news impact score of 0.20 on Accern's scale. They also gave news coverage about the company an impact score of 46.05 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Retractable Technologies?

Shares of RVP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Retractable Technologies' stock price today?

One share of RVP stock can currently be purchased for approximately $0.8298.

How big of a company is Retractable Technologies?

Retractable Technologies has a market capitalization of $31.74 million.

How can I contact Retractable Technologies?

Retractable Technologies' mailing address is 511 Lobo Ln, LITTLE ELM, TX 75068-5295, United States. The company can be reached via phone at +1-972-2941010.


MarketBeat Community Rating for Retractable Technologies (NYSEAMERICAN RVP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  50 (Vote Underperform)
Total Votes:  100
MarketBeat's community ratings are surveys of what our community members think about Retractable Technologies and other stocks. Vote "Outperform" if you believe RVP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RVP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.